Advertisement

The Scientist

» drug development and ecology

Most Recent

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: MERS Help on the Horizon?

MERS Help on the Horizon?

By | July 1, 2015

New research finds that a treatment for Middle East respiratory syndrome can prevent and treat the disease in mice, while an experimental vaccine moves into human testing.

0 Comments

image: 1 + 1 = 1

1 + 1 = 1

By | July 1, 2015

Nutrient levels in soil don’t add up when food chains combine.

0 Comments

image: Intelligence Gathering

Intelligence Gathering

By | July 1, 2015

Disease eradication in the 21st century

0 Comments

image: Ravenous Invasive Worm Now in U.S.

Ravenous Invasive Worm Now in U.S.

By | June 25, 2015

Researchers have found the New Guinea flatworm, one of the world’s most invasive species, in Florida, putting native ecosystems at serious risk.

0 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

image: Drug for Low Sex Drive in Women?

Drug for Low Sex Drive in Women?

By | June 8, 2015

A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.

1 Comment

image: Targeting Protein Domains with CRISPR

Targeting Protein Domains with CRISPR

By | May 13, 2015

Researchers use the genome-editing tool to mutate binding pockets and identify potential anti-cancer drug targets.

0 Comments

Advertisement

Popular Now

  1. Staying Active in the Lab
    Careers Staying Active in the Lab

    Retiring as a professor, and even shutting down your own lab, doesn’t necessarily mean quitting research.

  2. When Does a Smart Mouse Become Human?
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. Antibiotic Resistance Can Boost Bacterial Fitness
Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist